BROOKDALE SENIOR LIVING INC (BKD) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:BKD - US1124631045 - Common Stock
10.27 USD
+0.03 (+0.29%)
10.68 USD
+0.41 (+3.99%)
Taking everything into account, BKD scores 2 out of 10 in our fundamental rating. BKD was compared to 100 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of BKD have multiple concerns. BKD has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
BKD had negative earnings in the past year.
BKD had a positive operating cash flow in the past year.
BKD had negative earnings in 4 of the past 5 years.
BKD had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
With a Return On Assets value of -5.10%, BKD is not doing good in the industry: 68.00% of the companies in the same industry are doing better.
With a Return On Invested Capital value of 0.94%, BKD perfoms like the industry average, outperforming 41.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.1% | ||
| ROE | N/A | ||
| ROIC | 0.94% |
ROA(3y)-3.53%
ROA(5y)-2.19%
ROE(3y)-60.92%
ROE(5y)-37.35%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
BKD's Operating Margin of 1.98% is in line compared to the rest of the industry. BKD outperforms 48.00% of its industry peers.
BKD's Operating Margin has improved in the last couple of years.
BKD has a Gross Margin (26.14%) which is comparable to the rest of the industry.
BKD's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.98% | ||
| PM (TTM) | N/A | ||
| GM | 26.14% |
OM growth 3YN/A
OM growth 5Y54.21%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.08%
GM growth 5Y3.43%
2. Health
2.1 Basic Checks
BKD has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
BKD has more shares outstanding than it did 1 year ago.
The number of shares outstanding for BKD has been increased compared to 5 years ago.
BKD has a better debt/assets ratio than last year.
2.2 Solvency
BKD has an Altman-Z score of -0.20. This is a bad value and indicates that BKD is not financially healthy and even has some risk of bankruptcy.
BKD has a Altman-Z score of -0.20. This is amonst the worse of the industry: BKD underperforms 81.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -0.2 |
ROIC/WACC0.11
WACC8.45%
2.3 Liquidity
BKD has a Current Ratio of 0.84. This is a bad value and indicates that BKD is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.84, BKD is doing worse than 81.00% of the companies in the same industry.
BKD has a Quick Ratio of 0.84. This is a bad value and indicates that BKD is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of BKD (0.84) is worse than 72.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.84 | ||
| Quick Ratio | 0.84 |
3. Growth
3.1 Past
The earnings per share for BKD have decreased strongly by -11.96% in the last year.
BKD shows a small growth in Revenue. In the last year, the Revenue has grown by 3.93%.
Measured over the past years, BKD shows a decrease in Revenue. The Revenue has been decreasing by -5.08% on average per year.
EPS 1Y (TTM)-11.96%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%9.09%
Revenue 1Y (TTM)3.93%
Revenue growth 3Y4.25%
Revenue growth 5Y-5.08%
Sales Q2Q%3.7%
3.2 Future
Based on estimates for the next years, BKD will show a very strong growth in Earnings Per Share. The EPS will grow by 21.80% on average per year.
BKD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.35% yearly.
EPS Next Y-27.95%
EPS Next 2Y21.22%
EPS Next 3Y21.8%
EPS Next 5YN/A
Revenue Next Year2.37%
Revenue Next 2Y-1.21%
Revenue Next 3Y0.35%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for BKD. In the last year negative earnings were reported.
Also next year BKD is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as BKD.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 14.38 |
4.3 Compensation for Growth
A more expensive valuation may be justified as BKD's earnings are expected to grow with 21.80% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y21.22%
EPS Next 3Y21.8%
5. Dividend
5.1 Amount
No dividends for BKD!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
10.27
+0.03 (+0.29%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners101.48%
Inst Owner Change0.88%
Ins Owners0.86%
Ins Owner Change0.82%
Market Cap2.44B
Revenue(TTM)3.22B
Net Income(TTM)-306.65M
Analysts73.33
Price Target11.17 (8.76%)
Short Float %5.85%
Short Ratio3.93
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-23.44%
Min EPS beat(2)-30.56%
Max EPS beat(2)-16.31%
EPS beat(4)0
Avg EPS beat(4)-66.66%
Min EPS beat(4)-145.33%
Max EPS beat(4)-16.31%
EPS beat(8)1
Avg EPS beat(8)-45.29%
EPS beat(12)4
Avg EPS beat(12)-14.22%
EPS beat(16)5
Avg EPS beat(16)-14.09%
Revenue beat(2)0
Avg Revenue beat(2)-2.12%
Min Revenue beat(2)-2.69%
Max Revenue beat(2)-1.56%
Revenue beat(4)0
Avg Revenue beat(4)-1.68%
Min Revenue beat(4)-2.69%
Max Revenue beat(4)-1.1%
Revenue beat(8)0
Avg Revenue beat(8)-1.35%
Revenue beat(12)0
Avg Revenue beat(12)-1.08%
Revenue beat(16)0
Avg Revenue beat(16)-0.95%
PT rev (1m)44.08%
PT rev (3m)41.29%
EPS NQ rev (1m)-8.4%
EPS NQ rev (3m)-5.19%
EPS NY rev (1m)-41.82%
EPS NY rev (3m)-41.25%
Revenue NQ rev (1m)-1.02%
Revenue NQ rev (3m)-0.7%
Revenue NY rev (1m)-0.12%
Revenue NY rev (3m)0.06%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.76 | ||
| P/FCF | N/A | ||
| P/OCF | 10.67 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 14.38 |
EPS(TTM)-1.03
EYN/A
EPS(NY)-0.47
Fwd EYN/A
FCF(TTM)-1.59
FCFYN/A
OCF(TTM)0.96
OCFY9.37%
SpS13.55
BVpS-0.03
TBVpS-0.14
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.1% | ||
| ROE | N/A | ||
| ROCE | 1.19% | ||
| ROIC | 0.94% | ||
| ROICexc | 0.98% | ||
| ROICexgc | 0.99% | ||
| OM | 1.98% | ||
| PM (TTM) | N/A | ||
| GM | 26.14% | ||
| FCFM | N/A |
ROA(3y)-3.53%
ROA(5y)-2.19%
ROE(3y)-60.92%
ROE(5y)-37.35%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y47.69%
ROICexc growth 3YN/A
ROICexc growth 5Y48.52%
OM growth 3YN/A
OM growth 5Y54.21%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.08%
GM growth 5Y3.43%
F-Score6
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 9.3 | ||
| Cap/Depr | 157.39% | ||
| Cap/Sales | 18.86% | ||
| Interest Coverage | 0.27 | ||
| Cash Conversion | 50.84% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.84 | ||
| Quick Ratio | 0.84 | ||
| Altman-Z | -0.2 |
F-Score6
WACC8.45%
ROIC/WACC0.11
Cap/Depr(3y)69.44%
Cap/Depr(5y)87.89%
Cap/Sales(3y)8.28%
Cap/Sales(5y)9.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-11.96%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%9.09%
EPS Next Y-27.95%
EPS Next 2Y21.22%
EPS Next 3Y21.8%
EPS Next 5YN/A
Revenue 1Y (TTM)3.93%
Revenue growth 3Y4.25%
Revenue growth 5Y-5.08%
Sales Q2Q%3.7%
Revenue Next Year2.37%
Revenue Next 2Y-1.21%
Revenue Next 3Y0.35%
Revenue Next 5YN/A
EBIT growth 1Y9.9%
EBIT growth 3YN/A
EBIT growth 5Y46.37%
EBIT Next Year543.95%
EBIT Next 3Y97.67%
EBIT Next 5YN/A
FCF growth 1Y-177.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y168.73%
OCF growth 3YN/A
OCF growth 5Y-5.14%
BROOKDALE SENIOR LIVING INC / BKD FAQ
What is the ChartMill fundamental rating of BROOKDALE SENIOR LIVING INC (BKD) stock?
ChartMill assigns a fundamental rating of 2 / 10 to BKD.
What is the valuation status for BKD stock?
ChartMill assigns a valuation rating of 1 / 10 to BROOKDALE SENIOR LIVING INC (BKD). This can be considered as Overvalued.
How profitable is BROOKDALE SENIOR LIVING INC (BKD) stock?
BROOKDALE SENIOR LIVING INC (BKD) has a profitability rating of 3 / 10.
Can you provide the financial health for BKD stock?
The financial health rating of BROOKDALE SENIOR LIVING INC (BKD) is 0 / 10.
Can you provide the expected EPS growth for BKD stock?
The Earnings per Share (EPS) of BROOKDALE SENIOR LIVING INC (BKD) is expected to decline by -27.95% in the next year.